ArticleAnnals of medicine and surgery (2012)2024

Pirtobrutinib: a promising therapy for overcoming the resistance of ibrutinib in mantle cell lymphoma.

Sania Kaneez Fatima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.